F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus
F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus
Not yet recruiting · NCT06468683 · Registry updated 2024-06-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Not yet recruiting | Phase 1 | 2024-06-21 | NCT06468683 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Simnova Biotechnology Co.,Ltd. | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai jiaotong University School of Medicine,Renji Hospital | Shanghai | China | 1 |